Barentz bolsters India presence by acquiring Anshul Life Sciences

Global specialty ingredients solution provider Barentz International has acquired Indian business Anshul Life Sciences, a science focused specialty chemicals distributor. The business aims to establish a life science distribution platform in India, including in the personal care industry.

“We are extremely excited to welcome Anshul Life Sciences to the Barentz Group,” said Barentz Group’s APAC CEO Marc Duchene in a press release. “The acquisition underpins our ambitions to further grow in India, one of our key strategic markets, and the Asia Pacific region in general. The acquisition benefits our customers and principals by providing access to a broader portfolio of high-quality pharmaceuticals excipients and products and a deeper pool of expertise. We are delighted that Mr. Nagarajan will continue to lead the business. Together, we aim to enhance our offering and better serve the needs of the dynamic Indian market and beyond.”
 
Along with solidifying its commitment to the Indian market, Barentz’s acquisition of Anshul Life Sciences is also expected to open up further growth opportunities in the broader Asia Pacific region, according to the business. The deal also broadens Barentz’s personal care and nutraceuticals offering.
 
“Barentz aligns strongly with the entrepreneurial spirit and ethical standards of Anshul Life Science’s founding partners,” said Anshul Life Sciences’ CEO Nagarajan Kailasam. “We are excited to join the Barentz family and start our collaboration to capture the enormous potential of the Indian market by offering even more comprehensive solutions to our customers and principals in the Indian market and beyond. We are looking forward to the future and the growing international reach that this strategic move will bring to Anshul Life Sciences.”